Amneal FDA Tuesday, November 27, 2007 0.00 Neutral

FDA Approves OXYCODONE AND ACETAMINOPHEN — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals of New York LLC announced the FDA approval of its generic oxycodone and acetaminophen tablet, a milestone expected to bolster the company's presence in the competitive opioid analgesic market by increasing access to affordable pain management options.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day